Vertex Pharmaceuticals, Inc. (VRTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

50 NORTHERN AVENUE BOSTON, MA 02210

Vertex Pharmaceuticals develops and commercializes small molecule drugs for diseases including HIV infection, hepatitis C virus infection, and inflammatory and autoimmune disorders, cancer, pain and bacterial infection.

Data as of 2020-10-17
Market Cap56.803 Billion Shares Outstanding260.467 Million Avg 30-day Volume1.922 Million
P/E Ratio27.2 Dividend Yield EPS7.92
Price/Sales12.756 Price cash flow ratio21.4 Price free cash flow ratio41.9
Book Value28.87 Price to Tangible Book9.17 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.135654
BETA0.788777 52-week High/Low306.08 / 174.82 Stddev0.091974
View SEC Filings from VRTX instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 24 29 -17.24% 7 (0.46%) 11 (0.7%) -36.36%
Funds Holding: 927 833 11.28% 192 (12.52%) 182 (11.64%) 5.49%
13F shares: 240.351 Million 242.257 Million -0.79% 50.343 Million 53.924 Million -6.64%
% Ownership 92.2767 93.4385 -1.24% 19.3281 20.7986 -7.07%
New Positions: 165 132 25.0% 35 31 12.9%
Increased Positions 393 320 22.81% 80 64 25.0%
Closed Positions 60 86 -30.23% 20 26 -23.08%
Reduced Positions 263 274 -4.01% 62 74 -16.22%
Total Calls 1.116 Million 1.242 Million -10.17% 419.4 Thousand 365.9 Thousand 14.62%
Total Puts 1.113 Million 1.068 Million 4.25% 441.9 Thousand 335.4 Thousand 31.75%
PUT/CALL Ratio 1.0 0.86 16.28% 1.05 0.92 14.13%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10.5 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

8.7 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SACHS BRUCE I

  • Director
0 2020-10-15 7

MCKENZIE DIANA

  • Director
0 2020-10-15 4

BHATIA SANGEETA N.

  • Director
3,908 2020-10-05 3

MCGLYNN MARGARET G

  • Director
877 2020-08-25 4

SILVA PAUL M SVP & CONTROLLER

  • Officer
15,101 2020-08-06 17

ALTSHULER DAVID EVP, GLOBAL RESEARCH AND CSO

  • Officer
28,902 2020-08-06 16

PARINI MICHAEL EVP, CHIEF ADM, LEG & BD OFF

  • Officer
26,838 2020-08-06 19

KEWALRAMANI RESHMA CEO & PRESIDENT

  • Officer
  • Director
26,626 2020-08-06 11

SACHDEV AMIT EVP, CHIEF PATIENT OFFICER

  • Officer
49,987 2020-08-03 19

ARBUCKLE STUART A EVP, CHIEF COMMERCIAL OFFICER

  • Officer
35,319 2020-08-03 12

WAGNER CHARLES F JR EVP & CHIEF FINANCIAL OFFICER

  • Officer
16,126 2020-07-10 4

LEIDEN JEFFREY M EXECUTIVE CHAIRMAN

  • Officer
  • Director
2,701 2020-06-30 14

KEARNEY TERRENCE C

  • Director
0 2020-06-01 2

LEE YUCHUN

  • Director
0 2020-06-01 10

YOUNG WILLIAM D

  • Director
0 2020-06-01 3

GARBER ALAN M

  • Director
5,890 2020-06-01 1

CARNEY LLOYD

  • Director
3,559 2020-06-01 1

BOZIC CARMEN EVP AND CMO

  • Officer
13,991 2020-05-29 3

TATSIS OURANIA EVP, CHIEF REGULATORY OFFICER

  • Officer
12,738 2020-05-15 8

ULLIAN ELAINE

  • Director
0 2019-06-01 0

GRANEY THOMAS CHIEF FINANCIAL OFFICER

  • Officer
12,430 2018-10-01 0

SMITH IAN F EVP, COO

  • Officer
52,005 2018-06-29 0

CHODAKEWITZ JEFFREY EVP

  • Officer
No longer subject to file 2018-04-01 0

BOGER JOSHUA S

  • Director
No longer subject to file 2017-06-08 0

RILEY WAYNE JOSEPH

  • Director
0 2015-06-01 0

CONNOLLY THOMAS SVP, HUMAN RESOURCES

  • Officer
34,525 2014-12-12 0

HORTON KENNETH L EVP & CHIEF LEGAL OFFICER

  • Officer
72,419 2014-11-17 0

PACE MEGAN E SVP, CORP. COMMUNICATIONS

  • Officer
43,350 2014-11-17 0

MUELLER PETER EVP, GLOBAL R&D, CSO

  • Officer
169,088 2014-06-16 0

STAMOULIS CHRISTIANA SVP, CORP STRATEGY & BUS DEVLP

  • Officer
0 2013-07-30 0

KELLY LISA SVP, HUMAN RESOURCES

  • Officer
27,347 2013-02-05 0

EMMENS MATTHEW

  • Director
0 2012-06-01 0

WYSENSKI NANCY EVP, CHIEF COMMERCIAL OFFICER

  • Officer
32,232 2012-05-14 0

WINGER DENNIS L

  • Director
6,500 2012-03-09 0

HOWTON DAVID T SVP & CHIEF LEGAL OFFICER

  • Officer
19,703 2012-02-02 0

BOGER KENNETH S SVP & CHIEF LEGAL OFFICER

  • Officer
292,187 2011-09-13 0

CORDES EUGENE

  • Director
12,000 2011-03-17 0

SANDERS CHARLES A

  • Director
0 2010-06-01 0

COLLINSON STUART J

  • Director
0 2010-06-01 0

BRIMBLECOMBE ROGER W

  • Director
0 2010-03-15 0

GRAVES KURT EVP, CHIEF COMMERCIAL OFFICER

  • Officer
60,485 2009-10-19 0

GARRISON RICHARD C SVP AND CATALYST

  • Officer
38,782 2009-05-18 0

LEWIS-HALL FREDA C EVP, MEDICINES DEVELOPMENT

  • Officer
53,334 2009-03-19 0

BRANDT ERIC

  • Director
0 2009-01-29 0

ALAM JOHN J EVP, MED. DEV. GROUP & CMO

  • Officer
141,932 2008-10-01 0

POWER JOHANNA MESSINA VP & CONTROLLER

  • Officer
0 2008-07-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCKENZIE DIANA - Director

2020-10-19 16:13:59 -0400 2020-10-15 A 112 $222.81 a 138 direct

SACHS BRUCE I - Director

2020-10-19 16:15:16 -0400 2020-10-15 A 196 $222.81 a 12,629 direct

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 2,212 $268.61 d 3,908 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 1,787 $265.82 d 10,860 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 291 $262.66 d 14,133 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 2,670 $267.92 d 6,120 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 892 $264.60 d 12,647 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 M 8,729 $126.68 a 14,424 direct 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 M 8,729 d 0 direct

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 2,070 $266.66 d 8,790 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

BHATIA SANGEETA N. - Director

2020-10-07 16:11:31 -0400 2020-10-05 S 594 $263.54 d 13,539 direct yes 0.5288 -19.8302 2.8153 4 -19.8302 6

MCGLYNN MARGARET G - Director

2020-08-26 16:14:23 -0400 2020-08-25 G 3,707 d 877 direct -1.5966 -2.5224 -1.6002 2.7521 5 -6.8127 10

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments